GMP - Pharmaceutical Manufacturing

Good Manufacturing Practice (GMP) represents the set of principles and guidelines that ensure pharmaceutical and related products are consistently produced and controlled according to quality standards appropriate to their intended use. GMP regulations are enforced by regulatory authorities worldwide, including the European Medicines Agency (EMA), the Italian Medicines Agency (AIFA), and the U.S. Food and Drug Administration (FDA). GMP covers every aspect of production: from the starting materials, premises, and equipment used, to the training and personal hygiene of staff. Detailed, written procedures are essential for each process that could affect the quality of the finished product. Systems must be in place to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process, every time a product is made. Non-compliance with GMP can result in product recalls, manufacturing shutdowns, regulatory sanctions, and most critically, harm to patients. In an increasingly globalized pharmaceutical supply chain, GMP compliance is also essential for market access, as regulatory authorities in different jurisdictions rely on GMP certification as evidence of manufacturing quality. ICMED's consulting team brings deep expertise in GMP regulations across multiple sectors, helping clients navigate regulatory complexity while building practical, sustainable quality systems.

ICMED's GMP consulting services span multiple sectors within the pharmaceutical and life sciences industry: Pharmaceutical manufacturing facilities: Support for conventional pharmaceutical manufacturers producing solid dosage forms, liquids, semi-solids, and sterile products. This includes both large-scale commercial facilities and smaller compounding operations. Biotechnology companies: Specialized consulting for manufacturers of biological and biotechnological products, including recombinant proteins, monoclonal antibodies, vaccines, and cell-based therapies. These products present unique GMP challenges related to biological variability, complex manufacturing processes, and specialized testing requirements. Advanced Therapy Medicinal Products (ATMPs): Dedicated support for facilities manufacturing gene therapy products, somatic cell therapy products, and tissue-engineered products. ATMP manufacturing requires adaptation of traditional GMP principles to the unique characteristics of these innovative therapies. Medical device manufacturers: Consulting for companies producing medical devices, covering GMP requirements under both EU MDR and relevant national regulations, including quality management systems aligned with ISO 13485. Public hospital pharmacies: Support for hospital-based compounding and manufacturing units that must comply with GMP requirements while operating within the constraints of public healthcare institutions. Contract manufacturing organizations (CMOs): Assistance for CMOs in meeting the GMP expectations of multiple clients and regulatory authorities, including management of complex quality agreements and technology transfer processes. Regardless of the sector, ICMED's approach combines regulatory expertise with practical manufacturing knowledge, ensuring that quality systems are both compliant and operationally effective.